The Durability of Hope: What We've Learned About Spravato® in 2026
As Spravato® (esketamine) enters its seventh year of clinical use, real-world data from the ESCAPE-TRD and SUSTAIN-3 studies confirms the long-term durability of its effects. Explore how this rapid-acting treatment is redefining recovery for treatment-resistant depression.
6 min read
Read More